Feipu Yang

State Key Laboratory Of Drug Research
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Asymmetric Total Synthesis and Anti-Inflammatory Activity of Berbamine, Oxyacanthine, and Related Intermediates.

Asymmetric Total Synthesis and Anti-Inflammatory Activity of Berbamine, Oxyacanthine, and Related Intermediates.

Journal: Journal of natural products
Published: November 26, 2025

Design, synthesis, and biological profiling of novel aryl-spirocyclic diamine derivatives with potential antidepressant-like properties.

Design, synthesis, and biological profiling of novel aryl-spirocyclic diamine derivatives with potential antidepressant-like properties.

Journal: European journal of medicinal chemistry
Published: August 05, 2025

Structural Similarity in Natural Products Leading to Sample Misidentification: A Case Study of the Bisbenzylisoquinoline Alkaloids Oxyacanthine and Berbamine.

Structural Similarity in Natural Products Leading to Sample Misidentification: A Case Study of the Bisbenzylisoquinoline Alkaloids Oxyacanthine and Berbamine.

Journal: Journal of natural products
Published: January 09, 2025

Design, synthesis, and evaluation of novel oxyacanthine derivatives for anti-SARS-CoV-2 activity.

Design, synthesis, and evaluation of novel oxyacanthine derivatives for anti-SARS-CoV-2 activity.

Journal: Bioorganic & medicinal chemistry letters
Published: August 15, 2024

Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV -2.

Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV -2.

Journal: European journal of medicinal chemistry
Published: July 31, 2024

Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile.

Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile.

Journal: European journal of medicinal chemistry
Published: March 13, 2024

Improved and ligand-free copper-catalyzed cyclization for an efficient synthesis of benzimidazoles from o-bromoarylamine and nitriles.

Improved and ligand-free copper-catalyzed cyclization for an efficient synthesis of benzimidazoles from o-bromoarylamine and nitriles.

Journal: RSC advances
Published: January 10, 2024

Impurity study of tecovirimat.

Impurity study of tecovirimat.

Journal: Heliyon
Published: December 07, 2023

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids.

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids.

Journal: Journal of molecular and cellular cardiology
Published: June 02, 2023

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir.

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir.

Journal: Nature communications
Published: April 18, 2023

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.

Journal: Cell research
Published: February 15, 2021

Automated design and optimization of multitarget schizophrenia drug candidates by deep learning.

Automated design and optimization of multitarget schizophrenia drug candidates by deep learning.

Journal: European journal of medicinal chemistry
Published: March 20, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026